Sundo, Edjun M.
HRN: 26-68-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/11/2025
02/18/2025
IV
500mg
Every 8 Hours
Intestinal Amoebiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes